Radioiodinated N-[3-(4-morpholino)propyl]-N-methyl-2-hydroxy-5-iodo-3-methylbenzylamine (ERC9): a new potential melanoma imaging agent

Thomas G. Salopek, John R. Scott, Alummoottil V. Joshua, Michael Smylie, J. Wayne Logus, Carrie A. Morin, Alexander J.B. McEwan

Open source

DOI: 10.1007/s002590000455
Published: 2001-04
Container: European Journal of Nuclear Medicine
Publisher: Springer Science and Business Media LLC
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1007/s002590000455,
  title = {Radioiodinated N-[3-(4-morpholino)propyl]-N-methyl-2-hydroxy-5-iodo-3-methylbenzylamine (ERC9): a new potential melanoma imaging agent},
  author = {Thomas G. Salopek and John R. Scott and Alummoottil V. Joshua and Michael Smylie and J. Wayne Logus and Carrie A. Morin and Alexander J.B. McEwan},
  year = {2001},
  journal = {European Journal of Nuclear Medicine},
  doi = {10.1007/s002590000455},
  url = {https://doi.org/10.1007/s002590000455}
}

RIS

TY  - JOUR
TI  - Radioiodinated N-[3-(4-morpholino)propyl]-N-methyl-2-hydroxy-5-iodo-3-methylbenzylamine (ERC9): a new potential melanoma imaging agent
AU  - Thomas G. Salopek
AU  - John R. Scott
AU  - Alummoottil V. Joshua
AU  - Michael Smylie
AU  - J. Wayne Logus
AU  - Carrie A. Morin
AU  - Alexander J.B. McEwan
PY  - 2001
JO  - European Journal of Nuclear Medicine
DO  - 10.1007/s002590000455
UR  - https://doi.org/10.1007/s002590000455
ER  -

APA

Salopek, T. G., Scott, J. R., Joshua, A. V., Smylie, M., Logus, J. W., Morin, C. A., & McEwan, A. J. (2001). Radioiodinated N-[3-(4-morpholino)propyl]-N-methyl-2-hydroxy-5-iodo-3-methylbenzylamine (ERC9): a new potential melanoma imaging agent. European Journal of Nuclear Medicine. https://doi.org/10.1007/s002590000455

Source records

crossref · retrieved 2026-09-25T02:48:57.859Z